Wholesale Distributors Now Required to Fully Comply with DSCSA Enhanced Drug Distribution Standards

As of August 27, wholesale distributors are now required to fully comply with the enhanced drug distribution requirements outlined in the Drug Supply Chain Security Act (DSCSA). This marks the end of an exemption period previously granted by the U.S. Food and Drug Administration (FDA) and represents a significant step in efforts to bolster patient safety and improve the integrity of the pharmaceutical supply chain.

The DSCSA, enacted to create a more secure system for tracking prescription drugs as they move through the supply chain, mandates stricter standards for distributors. The conclusion of this exemption period means that all wholesale distributors must adhere to these enhanced protocols, which include measures designed to prevent counterfeit drugs from entering the market and ensure greater transparency in drug distribution. This development is part of broader regulatory efforts aimed at safeguarding public health and maintaining trust in pharmaceutical products.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: August 27, 2025

Author

Mark Chiang